TruthTides launches CME peptide course built to grade evidence, not promote protocols

TruthTides has opened enrollment for a 4-hour CME peptide course for clinicians, priced at $1,297 and including a year of access to its evidence library. The Chicago-based platform says the course is designed to help providers answer patient questions about peptide therapy without dosing charts or product promotion.

Why it matters: - TruthTides is targeting a gap in clinician education around peptide therapy, where much of the available training is tied to product sales or non-prescribing educators. - The course is built to give clinicians an evidence-based way to discuss peptide therapy with patients, colleagues, and licensing boards. - The enrollment launch adds a paid education product to TruthTides' broader peptide evidence platform.

What happened: - TruthTides opened enrollment in its 4-Hour CME Peptide Education Course on September 24, 2026. - The eight-module course is available now at truth-tides.com/courses for $1,297. - The course is taught by Adrienne Towsen, MD, TruthTides' Founding Clinical Advisor. - The program is aimed at physicians, nurse practitioners, physician assistants, nurses, and pharmacists. - Enrollment includes 12 months of TruthTides membership.

The details: - The course is accredited and awards 4 CE credits. - The activity is titled Clinical Application of Peptides: A Conservative, Evidence-Informed CME Course. - TruthTides and Pinnacle Conference, LLC planned and implemented the course. - Pinnacle Conference, LLC is jointly accredited by the ACCME, ACPE, and ANCC. - The activity provides up to 4 AMA PRA Category 1 Credits™ and 4 credits for nurses, pharmacists, physician assistants, social workers, dentists, athletic trainers, and interprofessional continuing education. - JA-PARS Activity ID is 203755826. - Credit is available from September 15, 2026 through September 15, 2029. - TruthTides says it accepted no funding from any pharmacy, supplier, or manufacturer to produce the course. - The company says the course contains no promotional material, no dosing instructions, no efficacy promises, and no claims that one peptide outperforms another. - Each compound is graded on study quality, study volume, and regulatory status, with monthly review. - The course includes access to a source-locked AI evidence engine, a verified physician directory listing, daily evidence and regulatory updates, and a monthly clinician call starting in October. - Modules cover patient evaluation, safety, compliance, decision frameworks, case studies, and special populations, followed by an assessment. - Access to the reference library remains open after the course ends and is searchable during patient visits. - The course includes 12 months of TruthTides membership. - The course is educational only and does not provide medical, legal, tax, or regulatory advice, contain dosing protocols, or certify any clinician in peptide therapy.

Between the lines: - TruthTides is positioning the course as an anti-marketing product in a space it says is crowded with sales-driven education. - The emphasis on grading evidence, source tracing, and searchable references suggests the company is trying to make the course useful in clinical and compliance settings, not just for CME credit. - The business model appears to pair continuing education with ongoing membership access, which gives TruthTides a recurring relationship with clinicians beyond the initial course purchase. - Christine Carrabba, VP of Education and Strategic Partnerships, said the fee pays for a course with no inside sales pitch and a year of access to the library used to check the material. - Adrienne Towsen said the course is meant to address a trust problem in peptide education and focuses on what the evidence actually shows.

What's next: - TruthTides said the monthly clinician call begins in October. - The company also said the same modules are available without CE credit through The Peptide Evidence Course. - A separate business offering, the Peptide Practice Blueprint, is set to launch in October. - Practices that want a program built for them can inquire about the Peptide Infrastructure Build at sales@truth-tides.com. - TruthTides says its broader platform continues to grade literature on compounded peptides and track regulatory status using verified sources.

The bottom line: - TruthTides is betting clinicians will pay for peptide education that strips out promotion and centers evidence, source checks, and compliance.